Drugs in development: bisphosphonates and metalloproteinase inhibitors - Wikidata - wikimedia - TriplyDB

Drugs in development: bisphosphonates and metalloproteinase inhibitors

Drugs in development: bisphosphonates and metalloproteinase inhibitors

http://www.wikidata.org/entity/Q24795847

about

Mithramycin downregulates proinflammatory cytokine-induced matrix metalloproteinase gene expression in articular chondrocytes Targets, models and challenges in osteoarthritis research Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis.Changes in serum and synovial fluid biomarkers after acute injury (NCT00332254).Anticancer effect of bisphosphonates: new insights from clinical trials and preclinical evidence.Biomechanical parameters of the BP-enriched bone cement.Modulation of bone turnover in orchidectomized rats treated with raloxifene and risedronate.Tracking bisphosphonates through a 20 mm thick porcine tissue by using surface-enhanced spatially offset Raman spectroscopy.Effect of bisphosphonates on periprosthetic bone loss after total knee arthroplasty: a meta-analysis of randomized controlled trials.

P2860

Q24817080-C7685376-CAE3-4768-AA82-E9890A192D46 Q26850147-F09130E6-FE17-4065-8329-5CB6C5CF4D41 Q33880198-5373908B-1F59-429D-A73B-B273D8B7D1F3 Q34614103-67EF2060-9FB6-41FA-8CCD-40CC5744D997 Q37845836-40B3A452-6FB4-4D51-A378-C995499F13E3 Q38816313-7547C26C-3AF4-4423-ABAF-A630C0BAE6EB Q44959484-BDA845ED-1381-4B5F-97B5-B7C5C031F45E Q48776627-05B86CFF-52D2-4F72-BA89-B14D515A8D5B Q55314148-CD0D27EB-D24E-4717-BDB6-7D15DB985730

P2860

Drugs in development: bisphosphonates and metalloproteinase inhibitors

http://www.wikidata.org/entity/Q24795847

description

2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Drugs in development: bisphosphonates and metalloproteinase inhibitors

@ast

Drugs in development: bisphosphonates and metalloproteinase inhibitors

@en

Drugs in development: bisphosphonates and metalloproteinase inhibitors

@nl

type

label

Drugs in development: bisphosphonates and metalloproteinase inhibitors

@ast

Drugs in development: bisphosphonates and metalloproteinase inhibitors

@en

Drugs in development: bisphosphonates and metalloproteinase inhibitors

@nl

prefLabel

Drugs in development: bisphosphonates and metalloproteinase inhibitors

@ast

Drugs in development: bisphosphonates and metalloproteinase inhibitors

@en

Drugs in development: bisphosphonates and metalloproteinase inhibitors

@nl

P1433

Q24795847-5996B8EC-242C-4758-87D0-D3C9FD551E49

P1476

Q24795847-6A9296A2-09C9-4DAF-B396-AC0239AC3474

P2093

Q24795847-BDA7B1D4-6D19-4292-A519-80B874CA9FED

Q24795847-FEF0B542-67AC-4C60-B8B6-EED9B4AC7A5D

P2860

Q24795847-0A60466C-3E93-499E-A926-8DA7A4BE054F

Q24795847-0CE00C15-1E70-4AEF-9C6A-8EA74EB7AF09

Q24795847-0D3F56DA-B91D-465C-A8FA-FF5B101B2D74

Q24795847-1432DCFD-7CF7-42AE-81DF-4E18C07037F1

Q24795847-15574504-157D-4A9B-8D32-298621748682

Q24795847-16A64987-3920-475A-A443-DE1ECA7B0E65

Q24795847-1A3229E4-B9D1-48D1-8D92-3527038DFB15

Q24795847-1A5BCDBF-FC8B-40D3-9CF4-BE3235996ED8

Q24795847-1B12D5CA-5A69-4D8A-8448-E20B0AA7E1BB

Q24795847-1D70513F-08C8-46BA-BF75-3C38D7991962

P2888

Q24795847-EDCA278F-A966-42E8-838C-1C0792A5C869

P304

Q24795847-3DAAA346-5291-473B-B7D8-45E2641B3C19

P31

Q24795847-7E489B07-65DB-491E-BFD7-941CDADBAA31

Q24795847-B852BD36-97AE-4B26-AFCA-281DE39844E4

P356

Q24795847-A11A3F45-85CF-47A2-B16B-21BFFA6088B9

P407

Q24795847-6A844E93-3983-45C3-B78F-F35904416145

P433

Q24795847-05267C43-9541-4663-BBDA-CD35BDF1ECA9

P478

Q24795847-5F47BDD5-48D7-4759-B951-A11226DA69B9

P577

Q24795847-8C8B89C3-076F-4300-98D7-C7D9E2504A79

Q24795847-AB88B330-FB83-479F-93D7-F6F2BFC51A39

P5875

Q24795847-E98A1E53-A536-4DFF-A932-829C0F12B13E

P6179

Q24795847-057372A6-80F9-4B80-88F5-BA43EAE2D533

P698

Q24795847-F16BD6F4-30C1-493A-8DC9-D41FEB2ECE4F

P921

Q24795847-21654046-E6D0-4A22-B0FD-9F6ED4B1531C

Q24795847-57EE50A0-4B23-46DD-B57F-C47449614D09

Q24795847-6887DE60-9F49-403E-8CB8-C0D819D25480

Q24795847-D6C5A50B-F560-4BFA-9D1A-339886B6404A

P932

Q24795847-421F1B15-68D7-4BE6-8F45-E0AD6D11C08C

P356

P1433

Arthritis Research and Therapy

P1476

Drugs in development: bisphosphonates and metalloproteinase inhibitors

@en

P2093

Jon B Catterall

http://www.w3.org/2001/XMLSchema#string

Tim E Cawston

http://www.w3.org/2001/XMLSchema#string

P2860

Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins

Lysosomal cysteine proteases: facts and opportunities.

Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage

MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes

ADAM, a novel family of membrane proteins containing A Disintegrin And Metalloprotease domain: multipotential functions in cell-cell and cell-matrix interactions

The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors

The small GTP-binding protein rac regulates growth factor-induced membrane ruffling

Role of CD47 as a marker of self on red blood cells

Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme

Human protein tyrosine phosphatase-sigma: alternative splicing and inhibition by bisphosphonates

P2888

P304

12-24

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR604

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2002-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2003-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10786974

http://www.w3.org/2001/XMLSchema#string

P6179

1030946913

http://www.w3.org/2001/XMLSchema#string

P698

12716443

http://www.w3.org/2001/XMLSchema#string

P921

organophosphorus compound

mechanism of action

P932

154424

http://www.w3.org/2001/XMLSchema#string